Recce Pharmaceuticals Ltd.ASX: RCE

Preliminary Final Report

· Issued by Recce Pharmaceuticals Ltd.

Filed with ASX · · 3 pages · English

Summary by 6ix AI

The report indicates a significant increase in the operating loss compared to the previous year, attributed to heightened research and development expenditures. The company did not declare any dividends during the financial year.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Recce Pharmaceuticals Ltd. on 6ix

Earlier from Recce Pharmaceuticals

Later from Recce Pharmaceuticals

All Recce Pharmaceuticals news releases